tiprankstipranks
Trending News
More News >
Taki Chemical Co., Ltd. (JP:4025)
:4025
Japanese Market
Advertisement

Taki Chemical Co., Ltd. (4025) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4025

Taki Chemical Co., Ltd.

(4025)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 4o)
Rating:77Outperform
Price Target:
¥3,311.00
▼(-12.52% Downside)
The stock of Taki Chemical Co., Ltd. scores well due to its strong financial performance, characterized by healthy revenue and profit growth, and a solid balance sheet. Technical indicators show positive momentum, while valuation metrics suggest the stock is reasonably priced despite a low dividend yield. The lack of earnings call data or notable corporate events does not affect the score significantly.

Taki Chemical Co., Ltd. (4025) vs. iShares MSCI Japan ETF (EWJ)

Taki Chemical Co., Ltd. Business Overview & Revenue Model

Company DescriptionTaki Chemical Co., Ltd. engages in the agri, chemicals, and real estate businesses in Japan. The company offers fertilizers and soil conditioners. It also provides water treatment chemicals, including polyaluminum chloride for drinking and industrial water treatment, urban sewage treatment, civil and factory wastewater treatment, and coagulation sedimentation and organic sludge filtration dehydrating agents. In addition, the company offers functional chemical materials, such as water-soluble aluminum salts, such as taxeram, aluminum phosphate binders, and takibine; chixosil; high-purity metal oxide consisting of high-purity tantalum and niobium pentaoxide; and functional nanomaterials. Further, it engages in the real estate business. The company serves customers in various fields, including agriculture, chemicals, functional materials, and biotechnology. The company was formerly known as Taki Fertilizer Manufacturing Co., Ltd. and changed its name to Taki Chemical Co., Ltd. in 1974. Taki Chemical Co., Ltd. was founded in 1885 and is headquartered in Kakogawa, Japan.
How the Company Makes MoneyTaki Chemical Co., Ltd. generates revenue primarily through the sale of its chemical products, which are tailored for specific applications across various industries. The company's revenue model is based on a combination of direct sales to end-users and partnerships with distributors and other manufacturers. Key revenue streams include specialty chemicals for automotive coatings, electronic materials for the semiconductor industry, and agricultural chemicals for crop protection. Additionally, Taki Chemical engages in long-term contracts with major clients, ensuring a steady income flow. The company's focus on innovation and quality has led to significant partnerships and collaborations with leading firms, further bolstering its market presence and financial performance.

Taki Chemical Co., Ltd. Financial Statement Overview

Summary
Taki Chemical Co., Ltd. exhibits strong financial health with solid revenue growth, improved profit margins, and a robust balance sheet with minimal leverage. The company has also shown significant improvement in cash generation despite previous negative free cash flows.
Income Statement
85
Very Positive
Taki Chemical Co., Ltd. has demonstrated solid revenue growth with a 11.65% increase in 2024. Its gross profit margin improved to 23.13%, indicating efficient cost management. The net profit margin increased to 5.91%, showcasing enhanced profitability. Both EBIT and EBITDA margins reflected healthy operational performance at 6.86% and 10.05% respectively. Overall, the company shows strong revenue and profit growth with robust margins, though there is room for improvement in EBIT margins.
Balance Sheet
88
Very Positive
The balance sheet of Taki Chemical Co., Ltd. is robust with a low debt-to-equity ratio of 0.03, indicating minimal reliance on debt financing. The equity ratio of 64.85% reflects a strong equity position relative to total assets. Moreover, the return on equity (ROE) is impressive at 6.07%, signifying efficient use of equity to generate profits. The company's financial position is stable with low leverage and high equity, reducing financial risk.
Cash Flow
80
Positive
The company has experienced a significant improvement in free cash flow, transitioning from negative in previous years to a positive 2.53 billion in 2024, indicating better cash management. The operating cash flow to net income ratio at 1.89 suggests strong cash generation capability relative to net income. However, while the free cash flow is positive this year, consistent positive free cash flow generation remains an area to watch.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue40.36B38.92B34.85B35.85B32.81B30.18B
Gross Profit9.80B9.01B6.93B8.81B8.56B7.49B
EBITDA4.81B4.52B3.12B4.33B3.88B3.24B
Net Income2.68B2.30B1.36B2.06B1.92B1.56B
Balance Sheet
Total Assets60.66B58.40B51.30B50.32B46.04B42.94B
Cash, Cash Equivalents and Short-Term Investments5.72B7.46B5.08B6.26B6.53B6.43B
Total Debt1.35B1.22B1.15B1.24B1.34B1.44B
Total Liabilities21.18B20.44B17.40B18.27B16.66B15.86B
Stockholders Equity39.05B37.88B33.82B31.95B29.23B26.93B
Cash Flow
Free Cash Flow0.002.53B-529.00M-34.00M218.00M1.88B
Operating Cash Flow0.004.34B1.62B1.44B2.82B3.02B
Investing Cash Flow0.00-1.61B-1.64B-1.08B-2.32B-1.01B
Financing Cash Flow0.00-352.00M-1.17B-543.00M-498.00M-561.00M

Taki Chemical Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price3785.00
Price Trends
50DMA
3735.40
Positive
100DMA
3307.94
Positive
200DMA
3286.82
Positive
Market Momentum
MACD
20.56
Positive
RSI
48.25
Neutral
STOCH
36.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4025, the sentiment is Neutral. The current price of 3785 is below the 20-day moving average (MA) of 3860.00, above the 50-day MA of 3735.40, and above the 200-day MA of 3286.82, indicating a neutral trend. The MACD of 20.56 indicates Positive momentum. The RSI at 48.25 is Neutral, neither overbought nor oversold. The STOCH value of 36.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4025.

Taki Chemical Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥23.36B9.253.85%6.41%-3.59%
77
Outperform
¥32.75B11.940.13%9.61%53.78%
74
Outperform
¥6.09B8.433.23%19.66%-13.42%
72
Outperform
¥29.17B5.864.53%3.47%33.32%
68
Neutral
¥51.83B20.630.66%14.95%-10.67%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
46
Neutral
€12.59B7.54-10.10%-18.84%-162.99%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4025
Taki Chemical Co., Ltd.
3,785.00
157.01
4.33%
JP:4080
Tanaka Chemical Corp.
390.00
-427.00
-52.26%
JP:4463
Nicca Chemical Co., Ltd.
1,482.00
316.89
27.20%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
279.00
18.74
7.20%
JP:4970
Toyo Gosei Co., Ltd.
6,720.00
-456.64
-6.36%
JP:5013
Yushiro Chemical Industry Co., Ltd.
2,165.00
641.12
42.07%

Taki Chemical Co., Ltd. Corporate Events

Taki Chemical Co., Ltd. Reports Strong First Half 2025 Financial Results
Aug 7, 2025

Taki Chemical Co., Ltd. reported significant growth in its consolidated financial results for the first half of 2025, with a notable increase in net sales and profits compared to the previous year. The company has revised its earnings forecast for the full year, anticipating continued growth, and announced a special dividend to commemorate its 140th anniversary, reflecting its strong financial position and commitment to shareholder returns.

Taki Chemical Co. Revises Earnings Forecasts and Announces Share Buyback
Aug 7, 2025

Taki Chemical Co., Ltd. announced an upward revision of its earnings and dividend forecasts for the fiscal year ending December 31, 2025, driven by improved sales and strategic financial decisions. The company plans to enhance shareholder value through a special and commemorative dividend and a share repurchase program, reflecting its commitment to capital efficiency and long-term growth.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 29, 2025